Megadose and minitransplantation: what is the biology?

Targeting GD2 after allogeneic SCT: effector cell composition defines the optimal use of ch14.18 and the bispecific antibody construct NG-CU (GD2-CD3).

Cancer immunology, immunotherapy : CII·2023

No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease.

Bone marrow transplantation·2021

Pediatric Langerhans cell histiocytosis: the impact of mutational profile on clinical progression and late sequelae.

Annals of hematology·2019

Monocytes show immunoregulatory capacity on CD4+ T cells in a human in-vitro model of extracorporeal photopheresis.

Clinical and experimental immunology·2018

Partial break in tolerance of NKG2A-/LIR-1- single KIR+ NK cells early in the course of HLA-matched, KIR-mismatched hematopoietic cell transplantation.

Bone marrow transplantation·2017

Improved immune recovery after transplantation of TCRαβ/CD19-depleted allografts from haploidentical donors in pediatric patients.

Bone marrow transplantation·2015

Multicenter validation study on post-thaw viability testing of cryopreserved hematopoietic progenitor cell products.

Cytotherapy·2026

Overcoming access barriers in European CAR-T therapy: the role of decentralized manufacturing and the EASYGEN framework.

Cytotherapy·2026

From classroom to cleanroom: building a skilled cell and gene therapy workforce.

Cytotherapy·2026

The evolving role of umbilical cord blood in transplantation, immunotherapy, and regenerative medicine: a brief contemporary review by the ISCT lab practices committee.

Cytotherapy·2026

MSC-delivered high-affinity variants of soluble PD1 lead to tumor regression.

Cytotherapy·2026

Retrospective comparison of mesenchymal stromal cells and antithymocyte globulin as second-line therapy for acute graft-versus-host disease.

Cytotherapy·2026

Treatment with CFTR modulators and subsequent remission of AA amyloidosis.

Clinical kidney journal·2026

Correction: Targeting oxidized phosphatidylcholines in SOD1-associated ALS: therapeutic potential of PC-OxPL-VecTab®.

Frontiers in neuroscience·2026

Comparison of Peg-INF plus TDF versus TDF Monotherapy in Indeterminate-phase Chronic Hepatitis B Patients with High HBsAg levels, HBeAg-negative status, and Normal ALT Levels.

Journal of clinical and translational hepatology·2026

Novel and Emerging Therapies for Childhood-Onset Movement Disorders.

Movement disorders : official journal of the Movement Disorder Society·2026

Implementation of soluble CD38 in blood crossmatching for patients on anti-CD38 therapy: A single-center experience.

Transfusion·2026

FAP+ pericyte-like cells promote monocyte differentiation into tumor-associated macrophages in glioblastoma.

Experimental & molecular medicine·2026

Related Experiment Videos

Megadose and minitransplantation: what is the biology?

Related Concept Videos

Targeting GD2 after allogeneic SCT: effector cell composition defines the optimal use of ch14.18 and the bispecific antibody construct NG-CU (GD2-CD3).

No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease.

Pediatric Langerhans cell histiocytosis: the impact of mutational profile on clinical progression and late sequelae.

Monocytes show immunoregulatory capacity on CD4+ T cells in a human in-vitro model of extracorporeal photopheresis.

Partial break in tolerance of NKG2A-/LIR-1- single KIR+ NK cells early in the course of HLA-matched, KIR-mismatched hematopoietic cell transplantation.

Improved immune recovery after transplantation of TCRαβ/CD19-depleted allografts from haploidentical donors in pediatric patients.

Multicenter validation study on post-thaw viability testing of cryopreserved hematopoietic progenitor cell products.

Overcoming access barriers in European CAR-T therapy: the role of decentralized manufacturing and the EASYGEN framework.

From classroom to cleanroom: building a skilled cell and gene therapy workforce.

The evolving role of umbilical cord blood in transplantation, immunotherapy, and regenerative medicine: a brief contemporary review by the ISCT lab practices committee.

MSC-delivered high-affinity variants of soluble PD1 lead to tumor regression.

Retrospective comparison of mesenchymal stromal cells and antithymocyte globulin as second-line therapy for acute graft-versus-host disease.

Treatment with CFTR modulators and subsequent remission of AA amyloidosis.

Correction: Targeting oxidized phosphatidylcholines in SOD1-associated ALS: therapeutic potential of PC-OxPL-VecTab®.

Comparison of Peg-INF plus TDF versus TDF Monotherapy in Indeterminate-phase Chronic Hepatitis B Patients with High HBsAg levels, HBeAg-negative status, and Normal ALT Levels.

Novel and Emerging Therapies for Childhood-Onset Movement Disorders.

Implementation of soluble CD38 in blood crossmatching for patients on anti-CD38 therapy: A single-center experience.

FAP+ pericyte-like cells promote monocyte differentiation into tumor-associated macrophages in glioblastoma.

Related Experiment Videos

Megadose and minitransplantation: what is the biology?

Related Concept Videos

Related Articles